We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

64 hedge funds and large institutions have $30.5M invested in Lumos Pharma, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more capital invested

Capital invested by funds: $16.3M → $30.5M (+$14.2M)

6% less funds holding

Funds holding: 68 → 64 (-4)

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

59% less call options, than puts

Call options by funds: $579K | Put options by funds: $1.42M

80% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 25

Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
25
Closed
14
Calls
$579K
Puts
$1.42M
Net Calls
-$838K
Net Calls Change
+$88K

Top Buyers

Rank Fund Capital Flow
1
LPC
Lion Point Capital
New York
+$4.94M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$125K
3
Verition Fund Management
Verition Fund Management
Connecticut
+$103K
4
BCM
Bridgeway Capital Management
Texas
+$83.2K
5
Morgan Stanley
Morgan Stanley
New York
+$61.9K

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$614K
2
EP
Eversept Partners
New York
-$434K
3
WVP
Worth Venture Partners
New Jersey
-$419K
4
RCM
Requisite Capital Management
Texas
-$412K
5
Millennium Management
Millennium Management
New York
-$155K
Name Holding Trade Value Shares
Change 		Change in
Stake
LA
26
LexAurum Advisors
Kansas
$132K – – –
Morgan Stanley
27
Morgan Stanley
New York
$131K +$61.9K +4,341 +305%
IA
28
IFP Advisors
Florida
$116K – – –
Citadel Advisors
29
Citadel Advisors
Florida
$77K -$2K -140 -4%
State Street
30
State Street
Massachusetts
$66K – – –
FTIOP
31
Fiduciary Trust International of Pennsylvania
Pennsylvania
$63K – – –
Wolverine Trading
32
Wolverine Trading
Illinois
$57K -$21K -1,473 -35%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$46K – – –
ARTA
34
A.R.T. Advisors
New York
$46K +$28.6K +2,008 New
AG
35
Advisor Group
Arizona
$44K – – –
Ameriprise
36
Ameriprise
Minnesota
$42K +$26.3K +1,845 New
Jane Street
37
Jane Street
New York
$40K +$25K +1,753 New
Cambridge Investment Research Advisors
38
Cambridge Investment Research Advisors
Iowa
$33K +$20.7K +1,448 New
FAM
39
Fenimore Asset Management
New York
$31K – – –
SBH
40
Segall Bryant & Hamill
Illinois
$29K – – –
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$28K +$17.8K +1,245 New
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$26K +$15.8K +1,111 +2,710%
BSW
43
Buckingham Strategic Wealth
Missouri
$25K – – –
WAM
44
Wealthspire Advisors (Maryland)
Maryland
$25K – – –
VCM
45
Versant Capital Management
Arizona
$20K – – –
UBS Group
46
UBS Group
Switzerland
$14K -$4.34K -304 -34%
MAM
47
Meeder Asset Management
Ohio
$10K -$5.02K -352 -46%
US Bancorp
48
US Bancorp
Minnesota
$8K – – –
SWM
49
Sugarloaf Wealth Management
Georgia
$6K +$3.97K +278 New
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$5K -$243 -17 -8%
1
2
3

LUMO Hedge Fund Activity: Q4 2019 in Review

64 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2019, worth a combined $30.5M — up 87% from $16.3M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of LUMO and 10 opened new positions — a net loss of 4 holders — while 25 trimmed existing stakes and 5 added.

The largest buyer was Lion Point Capital, opening a new position worth an estimated $4.94M. The largest seller was Oxford Asset Management, cutting an estimated $614K.

  • 64 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2019, down from 68 in Q3 2019.
  • Funds reported $30.5M of Lumos Pharma, Inc. Common Stock stock for Q4 2019, up 87% quarter-over-quarter.
  • 10 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2019 and 14 closed out, a net change of -4 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2019 was Lion Point Capital, an estimated $4.94M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2019 was Oxford Asset Management, an estimated $614K sold.

Based on aggregated 13F filings for Q4 2019.